Predicting Long-Term Prostate Cancer Mortality Risk After PSA Screening: Model Development and E

Annals of Internal Medicine (ACP) published a clinical update in Research Highlights on 13 Jan 2026. The item focuses on Predicting Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening Test: Prognostic Model Development and External Validation. Review the original article for the full source wording and details.